Indinol, capsules 300 mg, 120 pcs.
€67.48 €56.23
Properties of Indole-3-carbinol
Indole-3-carbinol is a universal corrector of pathological hyperplastic processes in the organs and tissues of the female reproductive system (breast, endometrium,
myometrium, cervix, ovaries). It normalizes the balance of estrogens in the body and suppresses their negative stimulating effect, as well as blocks other (hormone-independent) mechanisms,
activating pathological cell growth in the tissues of the breast and uterus. It has the ability to cause selective death of transformed cells with abnormally high
proliferative activity.
Indications
Indinol is recommended for use:
– for the prevention of cystic fibrosis mastopathy and as part of its comprehensive treatment, as well as for the correction of functional conditions of the mammary glands caused by this pathology;
– In combination with Epigallat® – in complex therapeutic treatment of endometriosis, adenomyosis, uterine myoma and endometrial hyperplasia without atypia, as well as for the prevention of recurrence of the mentioned diseases after surgical treatment;
– in complex treatment of genital diseases in women associated with human papilloma virus: cervical dysplasia (intraepithelial cervical
neoplasia), anogenital condylomatosis.
Composition
Indole-3-carbinol, lactose monohydrate, potato starch (corn), gelatin capsule (gelatin, water), microcrystalline cellulose (carrier), magnesium stearate (anti-caking agent).
Not GMO.
Not a drug.
How to take, the dosage
Contraindications
Side effects
Weight | 0.076 kg |
---|---|
Shelf life | 2 years. |
Conditions of storage | Store in a dry, protected from direct sunlight and out of reach of children at a temperature not exceeding 25 ° C. |
Manufacturer | MiraxBioPharma, Russia |
Medication form | capsules |
Brand | MiraxBioPharma |
Other forms…
Related products
Gynecology and Obstetrics
Prepidil, intracervical gel 0.5 mg/3 g syringes with catheter
Buy Indinol, capsules 300 mg, 120 pcs. with delivery to USA, UK, Europe and over 120 other countries.